Where is the immunochemistry reagents, analysers and test kits market heading?
Visiongain’s new 160-page report provides revenue forecasts to 2026 for the global immunochemistry market, 11 leading submarkets and 9 leading national markets.
This report forecasts the size of the immunochemistry market in the US, Japan, EU5: (Germany, France, Italy, Spain, UK), China, India, and the Rest of the World.
Along with revenue prediction for the overall world market, you see forecasts to 2026 for these submarkets: • Immunochemistry reagents and tests kits • Immunochemistry analysers
The study also forecasts immunochemistry reagents and tests kits subsectors: • Anaemia/Vitamin tests • Disease specific tests • Drugs of abuse/toxicology tests • Therapeutic drug monitoring • Endocrinology tests • Rapid tests
Our report provides revenues to 2026 for the sub-segments of the immunochemistry analysers, which includes: • Chemiluminescence analysers • ELISA analysers • Immunofluorescence analysers • Radioimmunoassay analysers
Assessments of the leading companies in the immunochemistry market – you find activities, products, capabilities and outlooks: • Roche • Siemens • Abbott • Danaher • Ortho Clinical Diagnostics • bioMerieux
Analysis of what stimulates and restrains the industry and market – assessments of challenges and strengths
Get our report Immunochemistry Reagents, Analysers and Test Kits Market Analysis : Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests,Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Executive Summary
1.1 Sector Highlights
1.2 Why You Should Read this Report
1.3 How this Study Delivers Information
1.4 Main Questions Answered by Our Analysis
1.5 Who is This Report For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
2. Introduction
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Types of IVD Tests
2.2.1 Point of Care Tests
2.2.2 Clinical Chemistry
2.2.3 Haematology
2.2.4 Microbiology
2.2.5 Genetic Testing
2.2.6 Immunochemistry
2.3 The Immune System
2.3.1 What is an Antigen?
2.3.2 What is an Antibody?
2.3.3 Antigen-Antibody Interaction
2.3.4 Affinity and Avidity of Antigen-Antibody Interactions
2.4 Polyclonal and Monoclonal Antibodies
2.5 Regulation of IVD Products
2.5.1 Regulation of IVD Products in the US
2.5.2 Regulation of IVD in the EU
2.5.3 Regulation of Laboratory Developed Tests
3. The Global Immunochemistry Market, 2016-2026
3.1 The Global Immunochemistry Market, 2016-2026
3.2 Global Immunochemistry Market Forecast, 2015-2026
3.3. Global Immunochemistry Market Trends, 2015-2026
3.3.1 High Demand Due to Increase in Chronic Patient Population
3.3.2 Automation of Laboratory Systems
3.3.3 Shift towards Decentralisation
3.3.4 Industry Consolidation
3.3.5 Investments by Private Equity/Venture Capital
3.3.6 Increased Awareness through Globalisation
3.4 Immunochemistry Market Drivers and Restraints, 2015-2026
4. Global Immunochemistry Reagents and Test Kits Market, 2015-2026
4.1 Introduction to Immunochemistry Reagents and Test Kits
4.2 Global Immunochemistry Reagents and Test Kits Market by Segment, 2016
4.3 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment, 2016-2026
4.4 Disease Specific Tests Market
4.4.1 Disease Specific Tests Market by Segment, 2016
4.4.2 Disease Specific Tests Market Forecast by Segment, 2015-2026
4.4.3 Disease Specific Tests Market: Drivers and Restraints, 2015-2026
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.
Visiongain Publishes Topical Drug Delivery Market Report 2022-2032
Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.
The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.
Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
